Entourage Health
Corp. (
TSX-V:ENTG)
(
OTCQX:ETRGF) (
FSE:4WE)
(“
Entourage” or the “
Company”), a
Canadian producer and distributor of award-winning cannabis
products is pleased to announce the appointment of James Afara as
the Company’s Chief Operating Officer (COO).
A results-driven leader with an exceptional
track record, James brings over 15 years of operations and supply
chain experience to Entourage, serving most recently as its Senior
Vice President of Strategic Sourcing, Quality Assurance and
Cultivation. His promotion comes at a pivotal time as the Company
integrates all functional teams in cultivation, tissue culture,
production, operations and supply chain under one leader, to align
core competencies and resources for maximum output.
“Our commercial success will always be driven by
our ability to scale production of our award-winning Color
Cannabis, Saturday and Starseed Medicinal products. Over the past
few months, James has demonstrated operational excellence in
building disciplined strategies to meet our aggressive sales
demand, while leading a team that consistently executes to plan,”
said George Scorsis, CEO and Executive Chairman. “With his proven
track record, business acumen and strong management outlook, James
is perfectly suited to oversee all functions related to bringing
saleable products to market, from seed to sale - straight through
to distribution. With the addition of James, we have solidified and
further strengthened our management team that will be pivotal to
meeting our revenue and profitability goals in the near term.”
James Afara, Chief Operating Officer, added:
“Entourage has an excellent reputation for producing top-shelf
flower and innovative products, as well as consistently meeting
fulfilment and delivery commitments. I’m proud to be expanding my
mandate alongside this industry’s top professionals – and leading
the very best cultivation and operations team in the business. We
are already noting positive results and driving value – the
benefits of which will eventually be passed along to our consumers,
patients and shareholders.”
Prior to joining Entourage in late 2021, James
served as the COO at CannTx Life Sciences. A professional engineer
by trade, James is widely recognized for his business analytics
strategies that helped commercialize proprietary tissue culture
remediation services and brought forward automated-operations
activities for cannabis produced both in small batches and at
scale. Over the past 15 years, James held manufacturing-related
leadership roles of increased responsibilities at SteriPro Canada
and Maple Leaf Foods. James holds a Bachelor of Science,
Biochemical Engineering Degree from Western University and has also
completed Leadership Certification courses from the Ivy School of
Business.
Mr. Scorsis concluded: “On behalf of the
Entourage team, I’d also like to acknowledge and whole-heartedly
thank Jeff Keyes, SVP of Operations, for his dedication to
optimizing our operations over the past three years. Under Jeff’s
watch, our provincial partners applauded Entourage for its stellar
production record, routinely naming the Company as a top performer
and shining example of efficiency and operational excellence. Jeff
recently advised he was stepping down to pursue a
manufacturing-focused role outside of the Company. We wish Jeff all
the best in his new pursuits and will always be indebted to him,
for his contributions to our success.”
Visit Entourage’s website here to access the
latest Company updates.
About Entourage Health
Corp.
Entourage Health Corp. is the publicly traded
parent Company of Entourage Brands Corp. (formerly WeedMD RX Inc.)
and CannTx Life Sciences Inc., licence holders producing and
distributing cannabis products for both the medical and adult-use
markets. The Company owns and operates a state-of-the-art hybrid
greenhouse and processing facility located on 158-acres in
Strathroy, ON; a fully licensed 26,000 sq. ft. Aylmer, ON
processing facility, specializing in cannabis extraction; and a
micropropagation, tissue culture and genetics centre-of-excellence
in Guelph, Ontario. With its Starseed Medicinal medical-centric
brand, Entourage has expanded its multi-channeled distribution
strategy. Starseed’s industry-first, exclusive partnership with
LiUNA, the largest construction union in Canada, along with
employers and over 10 union groups complements Entourage’s direct
sales to medical patients. Entourage’s elite adult-use product
portfolio includes Color Cannabis, Saturday Cannabis and Royal City
Cannabis Co.– sold across eight provincial distribution agencies.
It is the exclusive Canadian producer and distributor of
award-winning U.S.-based wellness brand Mary’s Medicinals sold in
both medical and adult-use channels. Under a collaboration with The
Boston Beer Company subsidiary, Entourage is also the exclusive
distributor of cannabis-infused beverages ‘TeaPot’ in Canada, which
launched in select provinces in summer 2022.
For more information, please visit us at
www.entouragehealthcorp.com
Follow Entourage and its brands on LinkedIn
Twitter: Entourage, Color Cannabis, Saturday
Cannabis, Starseed & Royal City Cannabis Co.
Instagram: Entourage, Color Cannabis, Saturday
Cannabis, Starseed & Royal City Cannabis Co.
For further information, investor or
media inquiries, please contact:
Marianella delaBarreraSVP, Communications &
Corporate
Affairs416-897-6644marianella@entouragecorp.com investor@entouragecorp.commedia@entouragecorp.com
Forward Looking Information
This press release contains "forward-looking information" within
the meaning of applicable Canadian securities legislation which are
based upon Entourage's current internal expectations, estimates,
projections, assumptions and beliefs and views of future events.
Forward-looking information can be identified by the use of
forward-looking terminology such as "expect", "likely", "may",
"will", "should", "intend", "anticipate", "potential", "proposed",
"estimate" and other similar words, including negative and
grammatical variations thereof, or statements that certain events
or conditions "may", "would" or "will" happen, or by discussions of
strategy.
The forward-looking information in this news
release is based upon the expectations, estimates, projections,
assumptions and views of future events which management believes to
be reasonable in the circumstances. Forward-looking information
includes estimates, plans, expectations, opinions, forecasts,
projections, targets, guidance or other statements that are not
statements of fact. Forward-looking information necessarily involve
known and unknown risks, including, without limitation, risks
associated with general economic conditions; adverse industry
events; loss of markets; future legislative and regulatory
developments; inability to access sufficient capital from internal
and external sources, and/or inability to access sufficient capital
on favourable terms; the cannabis industry
in Canada generally; the ability of Entourage to
implement its business strategies; the COVID-19 pandemic;
competition; crop failure; and other risks.
Any forward-looking information speaks only as
of the date on which it is made, and, except as required by law,
Entourage does not undertake any obligation to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise. New factors emerge from
time to time, and it is not possible for Entourage to predict all
such factors. When considering this forward-looking information,
readers should keep in mind the risk factors and other cautionary
statements in Entourage’s disclosure documents filed with the
applicable Canadian securities regulatory authorities on SEDAR at
www.sedar.com. The risk factors and other factors noted in the
disclosure documents could cause actual events or results to differ
materially from those described in any forward-looking
information.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS
REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE
POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Apr 2023 to Apr 2024